These drugs target some of the most pressing cancer types, including multiple myeloma, breast cancer, and bladder cancer ...

A study led by the Barcelona Institute for Global Health (ISGlobal) in collaboration with the Clínic-IDIBAPS, has shown, for ...

Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center, discusses some of the recent trends in cancer ...

During a live event, Xiuning Le, MD, PhD, discussed clinical trials of supportive care for infusion reaction and skin rash ...

Efti plus Keytruda and chemo achieved a 61% response rate in first-line advanced non-squamous non–small cell lung cancer, ...

When you are diagnosed with COPD, it is important to remember that you are not alone. A healthcare team, which may include a ...

Novel combination achieves 60.8% response rate and 90.2% disease control rate in first-line non-small cell lung cancer (1L ...

With lung tumour cases on the rise in India, robotic-assisted thoracic surgery offers a breakthrough—providing faster ...

The presentation titled " Utilization of Proteomic Testing in Pulmonary Nodule Risk Stratification at a Safety-Net Hospital: ...